Implante percutáneo o mínimamente invasivo de prótesis valvular aórtico (TAVI): una solución creciente para el tratamiento de la estenosis aórtica de pacientes inoperables y de alto riesgo para cirugía de reemplazo valvular aórtico (RVAO) / Implant percutaneous or minimally invasive aortic valve prosthesis (TAVI): a growing solution for the treatment of aortic stenosis of high risk and inoperable patients for valve replacement surgery Aortic (OAVR)
Rev. Hosp. Clin. Univ. Chile
;
26(1): 33-41, 2015. ilus
Artigo
em Espanhol
| LILACS
| ID: lil-788847
ABSTRACT
Aortic stenosis, the most common form of cardiac valve disease in the elderly, has an ominous prognosis, when the degree of stenosis is severe and symptoms develop. Symptoms and survival prognosis can be dramatically improved with open cardiac surgery and valve replacement. However in the presence of severe comorbidities and advanced age the risk of the operation can be extremely high in terms of mortality and postoperative morbidity. In the last decade the development of Transcatheter Aortic Valve Implantation (TAVI) has permitted the effective and safe treatment of these patients in a less invasive procedure involving the insertion and implantation of a valve prosthesis on a beating heart. In this article we describe the procedure characteristics, the selection process of candidates and discuss the results obtained with this technique...
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Estenose da Valva Aórtica
/
Próteses Valvulares Cardíacas
Tipo de estudo:
Estudo de etiologia
/
Estudos de avaliação
/
Estudo prognóstico
/
Fatores de risco
Limite:
Idoso
/
Aged80
/
Feminino
/
Humanos
/
Masculino
Idioma:
Espanhol
Revista:
Rev. Hosp. Clin. Univ. Chile
Assunto da revista:
Medicina
Ano de publicação:
2015
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Hospital Clínico Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS